SG11201406094XA - Quantification of impurities for release testing of peptide products - Google Patents

Quantification of impurities for release testing of peptide products

Info

Publication number
SG11201406094XA
SG11201406094XA SG11201406094XA SG11201406094XA SG11201406094XA SG 11201406094X A SG11201406094X A SG 11201406094XA SG 11201406094X A SG11201406094X A SG 11201406094XA SG 11201406094X A SG11201406094X A SG 11201406094XA SG 11201406094X A SG11201406094X A SG 11201406094XA
Authority
SG
Singapore
Prior art keywords
quantification
impurities
peptide products
release testing
testing
Prior art date
Application number
SG11201406094XA
Inventor
Martin Vogel
Werner Mueller
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of SG11201406094XA publication Critical patent/SG11201406094XA/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848Methods of protein analysis involving mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SG11201406094XA 2012-04-27 2013-04-25 Quantification of impurities for release testing of peptide products SG11201406094XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2012/057771 WO2013182217A1 (en) 2012-04-27 2012-04-27 Quantification of impurities for release testing of peptide products
PCT/EP2013/058619 WO2013160397A1 (en) 2012-04-27 2013-04-25 Quantification of impurities for release testing of peptide products

Publications (1)

Publication Number Publication Date
SG11201406094XA true SG11201406094XA (en) 2014-10-30

Family

ID=48227257

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201406094XA SG11201406094XA (en) 2012-04-27 2013-04-25 Quantification of impurities for release testing of peptide products

Country Status (16)

Country Link
JP (1) JP6121522B2 (en)
KR (1) KR102071737B1 (en)
CN (1) CN104246508B (en)
AR (1) AR090842A1 (en)
AU (1) AU2013254728B2 (en)
BR (1) BR112014026613B1 (en)
CA (1) CA2869041C (en)
DK (1) DK2841950T3 (en)
EA (1) EA029893B1 (en)
ES (1) ES2702712T3 (en)
HU (1) HUE042296T2 (en)
IL (1) IL234914A (en)
MX (1) MX353306B (en)
SG (1) SG11201406094XA (en)
TW (1) TWI589874B (en)
WO (2) WO2013182217A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA116217C2 (en) 2012-10-09 2018-02-26 Санофі Exendin-4 derivatives as dual glp1/glucagon agonists
CN104902919B (en) 2012-12-21 2018-11-20 赛诺菲 GLP1/GIP dual agonists or the triple agonists of GLP1/GIP/ glucagon
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
TW201609795A (en) 2013-12-13 2016-03-16 賽諾菲公司 EXENDIN-4 peptide analogues as dual GLP-1/GIP receptor agonists
TW201609796A (en) 2013-12-13 2016-03-16 賽諾菲公司 Non-acylated EXENDIN-4 peptide analogues
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
TW201625669A (en) 2014-04-07 2016-07-16 賽諾菲公司 Peptidic dual GLP-1/glucagon receptor agonists derived from Exendin-4
TW201625668A (en) 2014-04-07 2016-07-16 賽諾菲公司 Exendin-4 derivatives as peptidic dual GLP-1/glucagon receptor agonists
TW201625670A (en) 2014-04-07 2016-07-16 賽諾菲公司 Dual GLP-1/glucagon receptor agonists derived from EXENDIN-4
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
CN104211801A (en) * 2014-07-25 2014-12-17 杭州诺泰制药技术有限公司 Method for preparing lixisenatide
CN106153748B (en) * 2015-03-31 2019-02-22 深圳翰宇药业股份有限公司 N in a kind of detection polypeptide, the method for N- diisopropylcarbodiimide
AR105319A1 (en) 2015-06-05 2017-09-27 Sanofi Sa PROPHARMS THAT INCLUDE A DUAL AGONIST GLU-1 / GLUCAGON CONJUGATE HIALURONIC ACID CONNECTOR
TW201706291A (en) 2015-07-10 2017-02-16 賽諾菲公司 New EXENDIN-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonists
JP6505268B1 (en) * 2018-01-11 2019-04-24 株式会社日立ハイテクサイエンス Mass spectrometer and mass spectrometry method
TW202045927A (en) * 2019-02-27 2020-12-16 法商賽諾菲公司 Process for polysorbate quantification in a sample involving lc-ms with an internal standard

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244416T5 (en) * 1999-01-14 2020-01-03 Amylin Pharmaceuticals Llc Novel formulations of exendon agonists and their administration methods
US6451611B1 (en) * 2000-07-28 2002-09-17 Statens Serum Institute Quantitative analysis of hexose-monophosphates from biological samples
US7427675B2 (en) 2004-08-23 2008-09-23 Isis Pharmaceuticals, Inc. Compounds and methods for the characterization of oligonucleotides
DE102004043153B4 (en) * 2004-09-03 2013-11-21 Philipps-Universität Marburg Invention relating to GLP-1 and exendin
US20130137645A1 (en) * 2010-07-19 2013-05-30 Mary S. Rosendahl Modified peptides and proteins

Also Published As

Publication number Publication date
CN104246508A (en) 2014-12-24
JP2015515004A (en) 2015-05-21
MX353306B (en) 2018-01-08
TWI589874B (en) 2017-07-01
AU2013254728B2 (en) 2018-04-12
BR112014026613A2 (en) 2017-07-18
KR20150003794A (en) 2015-01-09
WO2013160397A1 (en) 2013-10-31
AR090842A1 (en) 2014-12-10
KR102071737B1 (en) 2020-01-30
CA2869041A1 (en) 2013-10-31
AU2013254728A1 (en) 2014-11-20
CN104246508B (en) 2016-06-08
WO2013182217A1 (en) 2013-12-12
TW201348701A (en) 2013-12-01
JP6121522B2 (en) 2017-04-26
MX2014012826A (en) 2015-11-13
HUE042296T2 (en) 2019-06-28
EA029893B1 (en) 2018-05-31
ES2702712T3 (en) 2019-03-05
DK2841950T3 (en) 2019-01-14
IL234914A (en) 2017-12-31
CA2869041C (en) 2021-05-04
BR112014026613B1 (en) 2021-12-21
EA201491974A1 (en) 2015-02-27

Similar Documents

Publication Publication Date Title
IL234914A (en) Quantification of impurities for release testing of peptide products
HK1249063A1 (en) Quick release plunger
IL235826A (en) Diazaspirocycloalkane and azaspirocycloalkane compounds and process for their preparation
EP2678451A4 (en) Molecular testing of multiple pregnancies
EP2854721A4 (en) Two-layer tension measurement system for compression garments
HK1213779A1 (en) Composition for immediate and extended release
EP2861655A4 (en) Methods for desolventization of bagasse
EP2873976A4 (en) Detection system of test substance
EP2726849A4 (en) Measurement of critical dimension
EP3054814A4 (en) Quick release sensor for merchandise display
GB2515417B (en) Method for determining mineralogical composition
SG11201502693SA (en) Nmr quantification of branched chain amino acids
IL236450A0 (en) Process for the preparation of 5-fluoro-1h-pyrazoles
PL399419A1 (en) Process for the preparation of 4-methoxydihydrochalcone
PL399418A1 (en) Process for the preparation of 4-methoxydihydrochalcone
EP2939014A4 (en) Methods for analysis of isomeric lipids
EP2859338A4 (en) Nmr quantification of tmao
IL235805A (en) Pyrimidinyl-diazaspiro compound and process for its preparation
EP2902015A4 (en) Preparation method of agomelatine solid preparation
HK1205197A1 (en) Assays for detection of glycosaminoglycans
EP2842131A4 (en) Calibration system for simultaneous calibration of multiple
LT2800973T (en) Methods and compounds for increasing sensitivity of botulinum assays
SI2639312T1 (en) Immunoassay for detection of miRNAs
EP2976326A4 (en) Process for preparation of 2-chloro-n-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide solid forms
IL233938A (en) Process for the preparation of substituted phenylpropanones